TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Double Bond Pharmaceutical AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,436
|
1,269
|
1,049 |
Financial expenses |
109
|
2,583
|
1,163 |
Earnings before taxes |
-10,624
|
-13,158
|
-17,345 |
EBITDA |
-10,320
|
-10,392
|
-16,016 |
Total assets |
4,544
|
4,551
|
11,301 |
Current assets |
4,087
|
3,957
|
9,250 |
Current liabilities |
2,488
|
3,021
|
3,660 |
Equity capital |
2,056
|
1,530
|
7,641 |
- share capital |
51
|
47
|
49 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.2%
|
33.6%
|
67.6% |
Turnover per employee |
144
|
127
|
105 |
Profit as a percentage of turnover |
-739.8%
|
-1036.9%
|
-1653.5% |
Return on assets (ROA) |
-231.4%
|
-232.4%
|
-143.2% |
Current ratio |
164.3%
|
131.0%
|
252.7% |
Return on equity (ROE) |
-516.7%
|
-860.0%
|
-227.0% |
Change turnover |
77
|
252
|
623 |
Change turnover % |
6%
|
25%
|
146% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.